Literature DB >> 12602959

Nitric oxide levels in Behçet's disease.

B Sancak1, M Onder, M O Oztas, N Bukan, M A Gürer.   

Abstract

Behçet's disease (BD) is a chronic multisystemic disorder which is characterized by a relapsing systemic inflammatory process. In certain inflammatory conditions such as rheumatoid arthritis, over production of nitric oxide (NO) could damage host cells and tissues, either directly and/or following reaction with other free radicals, such as superoxide anion to form species including peroxynitrite or hydroxyl radicals. Excessive superoxide radical production and impaired antioxidant mechanism in both the neutrophils and plasma of patients with BD have been reported. Our study was designed to investigate the role of NO in BD. NO is an extremely unstable molecule and rapidly converted in vivo and in vitro to nitrate (NO3-) and nitrite (NO2-). For this reason serum NO2- and NO3- have been used as an index of NO generation. We measured serum nitrate + nitrite levels, by using an enzymatic one-step methodology based on the reduction of nitrate to nitrite by nitrate reductase from Aspergillus species, in the presence of beta-NADPH. When compared to healthy controls, serum nitrate + nitrite levels were found to be higher in active periods of BD patients (P < 0.01). It was concluded that increased NO production in patients with BD might have critical biological activities relevant to vasculitic events in the active period of disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12602959     DOI: 10.1046/j.1468-3083.2003.t01-1-00574.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  7 in total

1.  Is Total Serum Nitrite and Nitrate (NOx) Level in Dengue Patients a Potential Prognostic Marker of Dengue Hemorrhagic Fever?

Authors:  Maheshi Mapalagamage; Shiroma Handunnetti; Gayani Premawansa; Sharmila Thillainathan; Tharanga Fernando; Karunayokiny Kanapathippillai; Rajitha Wickremasinghe; Aruna Dharshan De Silva; Sunil Premawansa
Journal:  Dis Markers       Date:  2018-07-05       Impact factor: 3.434

2.  Synovial nitric oxide concentrations are increased and correlated with serum levels in patients with active Behçet's disease: a pilot study.

Authors:  Fuat Duygulu; Cem Evereklioglu; Mustafa Calis; Murat Borlu; Mustafa Cekmen; Ozcan Ascioglu
Journal:  Clin Rheumatol       Date:  2005-05-18       Impact factor: 2.980

3.  Risk and prognostic factors of poor visual outcome in Behcet's disease with ocular involvement.

Authors:  Masaru Takeuchi; Hideyuki Hokama; Rintaroh Tsukahara; Takeshi Kezuka; Hiroshi Goto; Jun-Ichi Sakai; Masahiko Usui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-06-28       Impact factor: 3.117

4.  Behçet's Disease as a Model of Venous Thrombosis.

Authors:  Micaela La Regina; Armen Yuri Gasparyan; Francesco Orlandini; Domenico Prisco
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

5.  Assessment of serum homocysteine, endothelin-1, and nitric oxide levels in behçet's disease.

Authors:  Abeer A Hodeib; Tarek A Elsharawy; Hisham A Fawzi
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

6.  Influence of corticosteroid therapy on IL-18 and nitric oxide production during Behçet's disease.

Authors:  Fatmazohra Djaballah-Ider; Zineb Djeraba; Mourad Chemli; Nadjiba Dammene-Debbihe; Doulkifly Lounis; Houda Belguendouz; Yanis Medour; Samia Chaib; Chafia Touil-Boukoffa
Journal:  Inflammopharmacology       Date:  2018-03-29       Impact factor: 4.473

7.  Assessment of Plasma S-Nitrosothiol Concentration by Electron Paramagnetic Resonance Spectrometry and Plasma Nitrotyrosine Levels by ELISA in Behçet's Disease.

Authors:  Y D Akcay; I A Knight; E L Taylor; K Aksu; P G Winyard
Journal:  EJIFCC       Date:  2007-12-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.